These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29480994)

  • 21. Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma.
    Yang CH; Hung WC; Wang SL; Kang WY; Chen WT; Huang YC; Su YC; Chai CY
    APMIS; 2008 Apr; 116(4):309-16. PubMed ID: 18397466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
    Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
    Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.
    Levidou G; Saetta AA; Karlou M; Thymara I; Pratsinis H; Pavlopoulos P; Isaiadis D; Diamantopoulou K; Patsouris E; Korkolopoulou P
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1563-71. PubMed ID: 20174823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study.
    Degoricija M; Situm M; Korać J; Miljković A; Matić K; Paradžik M; Marinović Terzić I; Jerončić A; Tomić S; Terzić J
    World J Urol; 2014 Dec; 32(6):1469-75. PubMed ID: 24448750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
    Otoshi T; Tanaka T; Morimoto K; Nakatani T
    PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.
    Barboro P; Salvi S; Rubagotti A; Boccardo S; Spina B; Truini M; Carmignani G; Introini C; Ferrari N; Boccardo F; Balbi C
    Int J Oncol; 2014 May; 44(5):1589-98. PubMed ID: 24626777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue Profile of CDK4 and STAT3 as Possible Innovative Therapeutic Targets in Urinary Bladder Cancer.
    Aboushousha T; Hammam O; Aref A; Kamel A; Badawy M; Abdel Hamid A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):547-554. PubMed ID: 32102537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
    Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
    J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis.
    Ren B; Li W; Yang Y; Wu S
    World J Surg Oncol; 2014 Mar; 12():55. PubMed ID: 24602161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of p27kip1 in urinary bladder urothelial carcinoma.
    Fu TY; Tu MS; Tseng HH; Wang JS
    Int J Urol; 2007 Dec; 14(12):1084-7. PubMed ID: 18036045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
    Holmäng S; Andius P; Hedelin H; Wester K; Busch C; Johansson SL
    J Urol; 2001 Apr; 165(4):1124-8; discussion 1128-30. PubMed ID: 11257652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
    Wagner U; Süess K; Luginbühl T; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Jordan P; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    J Pathol; 1999 May; 188(1):44-50. PubMed ID: 10398139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGP 9.5 and cyclin D1 coexpression in cutaneous squamous cell carcinomas.
    Mastoraki A; Ioannidis E; Apostolaki A; Patsouris E; Aroni K
    Int J Surg Pathol; 2009 Dec; 17(6):413-20. PubMed ID: 19443866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
    Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
    BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.
    Celis JE; Ostergaard M; Basse B; Celis A; Lauridsen JB; Ratz GP; Andersen I; Hein B; Wolf H; Orntoft TF; Rasmussen HH
    Cancer Res; 1996 Oct; 56(20):4782-90. PubMed ID: 8840999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.
    Ding S; Xing N; Lu J; Zhang H; Nishizawa K; Liu S; Yuan X; Qin Y; Liu Y; Ogawa O; Nishiyama H
    Int J Urol; 2011 Jun; 18(6):432-8. PubMed ID: 21449971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.